June 2017 Newsletter

A brief history of the cystic fibrosis therapy…Oscar Moran - Istituto di Biofisica, CNR, Genova, ItalyCystic fibrosis (CF) is the most common se­vere recessive hereditary disease in Cauca­sians. In Europe, CF affects 1 in 2000–3000 newborns. CF has a complex and greatly variable clinical expression, involving airways, pancreas, male genital system, intestine, liver, bone, and kidney. Some of the disease ...

December 2016 Newsletter

TAT-CF: Novel therapeutic approaches for the treatment of cystic fibrosis based on small molecule transmembrane anion transportersTAT-CF is a collaborative project coordinated by the University of Burgos, which has been formally launched on 1st of January 2016 with an expected duration of 36 months. Apart from the University of Burgos, the consortium is formed by 3 research centres: CSIC-Consejo Superior ...